1. Home
  2. KDLY vs ENSC Comparison

KDLY vs ENSC Comparison

Compare KDLY & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KDLY
  • ENSC
  • Stock Information
  • Founded
  • KDLY 2019
  • ENSC 2003
  • Country
  • KDLY United States
  • ENSC United States
  • Employees
  • KDLY N/A
  • ENSC N/A
  • Industry
  • KDLY
  • ENSC Biotechnology: Pharmaceutical Preparations
  • Sector
  • KDLY
  • ENSC Health Care
  • Exchange
  • KDLY NYSE
  • ENSC Nasdaq
  • Market Cap
  • KDLY 7.8M
  • ENSC 7.9M
  • IPO Year
  • KDLY 2024
  • ENSC N/A
  • Fundamental
  • Price
  • KDLY $1.25
  • ENSC $5.80
  • Analyst Decision
  • KDLY
  • ENSC
  • Analyst Count
  • KDLY 0
  • ENSC 0
  • Target Price
  • KDLY N/A
  • ENSC N/A
  • AVG Volume (30 Days)
  • KDLY 55.8K
  • ENSC 58.7K
  • Earning Date
  • KDLY 02-18-2025
  • ENSC 03-14-2025
  • Dividend Yield
  • KDLY N/A
  • ENSC N/A
  • EPS Growth
  • KDLY N/A
  • ENSC N/A
  • EPS
  • KDLY N/A
  • ENSC N/A
  • Revenue
  • KDLY $2,875,400.00
  • ENSC $4,421,404.00
  • Revenue This Year
  • KDLY N/A
  • ENSC $89.78
  • Revenue Next Year
  • KDLY N/A
  • ENSC N/A
  • P/E Ratio
  • KDLY N/A
  • ENSC N/A
  • Revenue Growth
  • KDLY N/A
  • ENSC 40.41
  • 52 Week Low
  • KDLY $0.65
  • ENSC $2.12
  • 52 Week High
  • KDLY $4.20
  • ENSC $17.25
  • Technical
  • Relative Strength Index (RSI)
  • KDLY N/A
  • ENSC 35.65
  • Support Level
  • KDLY N/A
  • ENSC $5.55
  • Resistance Level
  • KDLY N/A
  • ENSC $6.46
  • Average True Range (ATR)
  • KDLY 0.00
  • ENSC 0.62
  • MACD
  • KDLY 0.00
  • ENSC -0.13
  • Stochastic Oscillator
  • KDLY 0.00
  • ENSC 7.31

About KDLY KINDLY MD INC

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: